By submitting this form, you are agreeing to the Terms of Use and Privacy Policy.
Pharma-grade PET blister films are being well accepted in the pharmaceutical packaging industry because of their high property and environmental advantages. This film is mainly used in solid oral medications, which give better protection from moisture, oxygen, and light. While the traditional PVC blister film is not very eco-friendly, PET is a much more sustainable alternative for use as packaging. PET is highly recyclable, which helps point the pharmaceutical industry toward making the endeavour greener and more environmentally friendly.
The upsurge in chronic diseases and prescription drugs is now one of the major factors witnessed in rising demand for pharma-grade PET blister films. Such films not only provide assurance of product safety and stability but also bring along high safety security features like tamper evidence. As pharmaceutical companies advance on more rigid guidelines concerning higher safety and sustainability, pharma-grade PET blister film adoption is slated to speed up in the coming years, with high emphasis on ecologically friendly packaging.
The global pharma-grade PET blister film market has mainly been driven by the need for sustainable and recyclable solutions for packaging. On the global front, governments and regulatory bodies have consciously worked towards introducing greener alternatives to traditional materials like PVC, thus driving pharmaceutical companies to increasingly adopt PET films.
PET films also possess another very important reason, such as superior barrier properties. They resist moisture, oxygen, and UV light. By this packaging, sensitive medications such as antibiotics are treated with a much increased shelf life. These have now become the first choice for pharmaceutical packaging.
However, the per se disadvantage of PET films being costlier than PVC lingers in the backdrop. Though PET has a sustainable environmental advantage over a long term, switching over to PET films would entail substantial expenditure as a one-off cost for smaller pharmaceutical companies. However, as the technology develops, the cost of production would come down, and the market size would increase.
Market for pharma-grade PET blister film to grow by 5-7% compound annual growth rate for the next five years, based on an increasingly necessary sustainable and secured pharmaceutical packaging. Major factors driving the expansion of this market include regulatory changes and factors of environmental responsibility, primarily through the shifting focal points of the pharmaceutical industry to such issues.
North America and Europe are expected to be the largest consumers, but the market is likely to exceed $1.5 billion by 2030. The Asia-Pacific region is set to experience the fastest growth due to the rapid expansion of the pharmaceutical sector across countries in the region like India and China.
By Geography:
By End User:
By Technology:
By Application:
The pharmaceutical-grade PET blister films market is highly competitive globally, with large and other players working hard on innovative products to meet pharmaceuticals’ demand for sustainable high-performance packages. Klöckner Pentaplast, Tekni-Plex, and Amcor are but a few companies that take the lead by utilising eco-friendly blister films featuring the excellent barrier properties at a much lesser environmental impact.
Increased focus on recyclability has led to an increasing trend of R&D investments aimed at improving PET blister film performance. Manufacturers are working on enhancing the strength and barrier resistance of these films with a lower production cost; this enhances their accessibility to more pharmaceutical companies.
Packaging manufacturers work in collaboration with the pharmaceuticals industry to ensure innovations in the market. Collaboration focuses on ensuring that the films should satisfy the exigent regulatory requirements for pharmaceutical packaging while endorsing the burgeoning interest in the sustainability front of the industry.
The increasing use of PET blister films by local players in developing Asian markets, including the Asia-Pacific region, is indeed in step with the implementation of international packaging standards being followed by local pharmaceutical companies. This gives a competitive opportunity for global players to enhance their market coverage in these markets.
